Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired α-cell responses in type 1 diabetes

Diabetes

Volumn 47, Issue 7, 1998, Pages 995-1005

  Taborsky Jr , Gerald J ^a,b,e   Ahrén, Bo ^c   Havel, Peter J ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Div of Reproductive Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN;

AUTONOMIC NERVOUS SYSTEM; DIABETES CONTROL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MEDIATOR RELEASE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; GLUCAGON; HUMANS; HYPOGLYCEMIA; INSULIN; ISLETS OF LANGERHANS;

EID: 2642593026     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.7.995     Document Type: Review

References (114)

1. Cryer PE, Gerich JE: Hypoglycemia in insulin dependent diabetes mellitus: interplay of insulin excess and compromised glucose counterregulation. In Diabetes Mellitus. Porte D Jr, Sherwin RS, Eds. Stamford, CT, Appleton & Lange, 1997, p. 745-760
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. The Diabetes Control and Complications Trial Research Group: Hypogly-cemia in the diabetes control and complications trial. Diabetes 46:271-286, 1997
4. Cryer PE: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389, 1994
5. Gerich JE: Lilly lecture 1988: glucose counterregulation and its impact on diabetes mellitus. Diabetes 37:1608-1617, 1988
6. Cryer PE, Gerich J: Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine. Diabetes Care 6:95-99, 1983
7. De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 260:E203-E212, 1991
8. De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol 261:E725-E736, 1991
9. De Feo P, Perriello G, De Cosmo S, Ventura MW, Campbell PJ, Brunetti P, Gerich JE, Bolli GB: Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569, 1986
10. Arias P, Kerner W, Zier H, Navascues I, Pfeiffer EF: Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment: assessment by means of semi-ambulatory 24-hour continuous blood glucose monitoring. Diabetes 8:134-140, 1985
11. Bergenstal RM, Polonsky KS, Pons G, Jaspan JB, Rubenstein AH: Lack of glucagon response to hypoglycemia in type 1 diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pump. Diabetes 32:398-402, 1983
12. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS: Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
13. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
14. Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE, Gerich JE: Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. New Engl J Med 310:1706-1711, 1984
15. Bolli G, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE: Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134-141, 1983
16. Gerich J, Charles M, Grodsky G: Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest 54:833-841, 1974
17. Pipeleers DG, Schuit FC, Van Schravendijk CF, Van de Winkel M: Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117:817-823, 1985
18. Samols E, Tyler J, Marks V: Glucagon-insulin interrelationships. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. Lefebvre P, Unger RH, Eds. Oxford, U.K., Pergamon, 1972, p. 151-173
19. Weir GC, Knowlton SD, Atkins RF, McKennan KX, Martin DB: Glucagon secretion from the perfused pancreas of streptozotocin-treated rats. Diabetes 25:275-282, 1976
20. Samols E, Weir GC, Bonner-Weir S: Intraislet insulin-glucagon-somatostatin relationships. In Glucagon II . Lefebvre PJ, Ed. Berlin, Springer, 1983, p. 133-173
21. Bonner-Weir S, Orci L: New perspectives on the microvascularure of the islets of Langerhans in the rat. Diabetes 31:883-889, 1982
22. Stagner JI, Samols E: Retrograde perfusion as a method for testing the relative effects of glucose on the A cell. J Clin Invest 77:1034-1037, 1986
23. Samols E, Stagner JI: Intra-islet regulation. Am J Med 85:31-35, 1988
24. Van Schravendijk CF, Foriers A, Hooghe-Peters EL, Rogiers V, De Meyts P, Sodoyez JC, Pipeleers DG: Pancreatic hormone receptors on islet cells. Endocrinology 117:841-848, 1985
25. Rorsman P, Berggren PO, Bokvist K, Ericson H, Mohler H, Ostenson CG, Smith PA: Glucose-inhibition of glucagon secretion involves activation of GABA A-receptor chloride channels. Nature 341:233-236, 1989
26. Van Schravendjjk CF, Foriers A, Van den Brande JL, Pipeleers DG: Evidence for the presence of type 1 insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121:1784-1788, 1987
27. Unger RH: Insulin-glucagon relationships in the defense against hypogly-cemia. Diabetes 32:575-583, 1983
28. Samols E: Glucagon and insulin secretion. In Handbook of Experimental Pharmacology. Lefebvre PJ, Ed. Berlin, Springer, 1983, p. 485-518
29. Asplin CM, Paquette TL, Palmer JP: In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest 68:314-318, 1981
30. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH: Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74:2296-2299, 1984
31. Tominaga M, Maruyama H, Vasko MR, Baetens D, Orci L, Unger RH: Morphologic and functional changes in sympathetic nerve relationships with pancreatic alpha-cells after destruction of beta-cells in rats. Diabetes 36:365-373, 1987
32. Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, Brunetti P, Unger R: Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. J Clin Invest 73:917-922, 1984
33. Havel PJ, Taborsky GJ Jr: The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr Rev 10:332-350, 1989
34. Taborsky GJ Jr., Havel PJ, Porte D Jr: Stress-induced activation of the neuroendocrine system and its effects on carbohydrate metabolism. In Diabetes Mellitus. Porte D Jr, Sherwin RS, Eds. Stamford, CT, Appleton & Lange, 1997, p. 141-168
35. Havel PJ, Mundinger TO, Veith RC, Dunning BE, Taborsky GJ Jr: Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs. Am J Physiol 263:E8-E16, 1992
36. Dunning BE, Scott MF, Neal DW, Cherrington AD: Direct quantification of nor-epinephrine spillover and hormone output from the pancreas of the conscious dog. Am J Physiol 272:E746-E755, 1997
37. Schwartz TW: Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85:1411-1425, 1983
38. Samols E, Weir GC: Adrenergic modulation of pancreatic A, B and D cells: α-Adrenergic suppression and β-adrenergic stimulation of somatostatin secretion, α-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest 63:230-238, 1979
39. Gerich JE, Karam JH, Forsham PH: Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab 37:479-481, 1973
40. Marliss EB, Girardier L, Seydoux J, Wollheim CB, Kanazawa Y, Orci L, Renold AE, Porte D Jr Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest 52:1246-1259, 1973
41. Ahren B, Veith RC, Taborsky GJ Jr Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1. Effects on basal release of insulin and glucagon. Endocrinology 121:323-331, 1987
42. Dunning BE, Ahren B, Veith RC, Bottcher G, Sundler F, Taborsky GJ Jr: Galanin: a novel pancreatic neuropeptide. Am J Physiol 251:E127-E133, 1986
43. Kaneto A, Miki E, Kosaka K: Effects of vagal stimulation on glucagon and insulin secretion. Endocrinology 95:1005-1010, 1974
44. Bloom SR, Edwards AV: Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. J Physiol (Lond) 315:31-41, 1981
45. Kaneto A, Kajinuma H, Kosaka K, Nakao K: Stimulation of insulin secretion by parasympathomimetic agents. Endocrinology 83:651-658, 1968
46. Lindkaer S, Jensen J, Fahrenkrug J, Hoist JJ, Nielsen OV, Schaffalitzky de Muckadell OB: Secretory effects of VIP on isolated perfused porcine pancreas. Am J Physiol 235:E387-E391, 1978
47. Havel PJ, Dunning BE, Verchere CB, Baskin DG, O'Dorisio T, Taborsky GJ Jr Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs. Regul Pept 71:163-170, 1997
48. Christensen NJ, Iversen J: Release of large amounts of noradrenaline from the isolated perfused canine pancreas during glucose deprivation. Diabetologia 9:396-399, 1973
49. Hisatomi A, Maruyama H, Orci L, Vasko M, Unger RH: Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. J Clin Invest 75:420-426, 1985
50. Stagner J, Samols E, Polonsky K, Pugh W: Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas. J Clin Invest 78:1193-1198, 1986
51. Luzi L, Battezzati A, Perseghin G, Bianchi E, Vergani S, Secchi A, La Rocca E, Staudacher C, Sporti D, Ferrari G, Di Carlo V, Pozza G: Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes 41:1632-1639, 1992
52. Miller RE, Waid TH, Joyce MP: Direct neural inhibition of insulin secretion in response to systemic hypoglycemia. Am J Physiol 230:1090-1094, 1976
53. Patel DG: Role of parasympathetic nervous system in glucagon response to insulin-induced hypoglycemia in normal and diabetic rats. Metabolism 33:1123-1127, 1984
54. Bloom SR, Edwards AV, Vaughan NJA: The role of the autonomic innervation in the control of glucagon release during hypoglycemia in the calf. J Physiol (Lond) 236:611-623, 1974
55. Havel PJ, Veith RC, Dunning BE, Taborsky GJ Jr: Role for autonomic nervous system to increase pancreatic glucagon secretion during marked insulin-induced hypoglycemia in dogs. Diabetes 40:1107-1114, 1991
56. Havel PJ, Akpan JO, Curry DL, Stern JS, Gingerich RL, Ahren B: Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglu-copenia and hypoglycemia in mice. Am J Physiol 265:R246-R254, 1993
57. Havel PJ, Valverde C: Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes 45:960-966, 1996
58. Havel PJ, Taborsky GJ Jr: The contribution of the autonomic nervous system to increased glucagon secretion during hypoglycemic stress: update, 1994. Endo Rev Monographs 2:201-204, 1994
59. Diggers DW, Myers SR, Neal D, Stinson R, Cooper NB, Jaspan JB, Williams PE, Cherrington AD, Fizzell RT: Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 37:7-16, 1989
60. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI: Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 93:1677-1682, 1994
61. Borg MA, Sherwin RS, During MJ, Borg WP, Shulman GI: Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 99:361-365, 1997
62. Havel PJ, Parry SJ, Stern JS, Akpan JO, Gingerich RL, Taborsky GJ Jr, Curry DL: Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. Metabolism 43:860-866, 1994
63. Havel PJ, Mundinger TO, Taborsky GJ Jr: Pancreatic sympathetic nerves increase glucagon secretion during severe hypoglycemia in dogs. Am J Physiol 270:E20-E26, 1996
64. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
65. Dagogo-Jack S, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
66. Powell AM, Sherwin RS, Shulman GI: Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. J Clin Invest 92:2667-2674, 1993
67. Pacak K, Palkovits M, Kvetnansky Y, Matern P, Hart C, Kopin I, Goldstein DS: Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 136:4814-4819, 1995
68. Luo X, Kiss A, Rabadan-Diehl C, Aguliera G: Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor message ribonucleic acid by adrenalectomy and glucocorticoids. Endocrinology 136:3877-3883, 1995
69. Brown MR, Gray TS, Fisher LA: Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function. Regul Pept 30:321-329, 1986
70. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98:680-691, 1996
71. Pampanelli S, Lalli C, Del Sindaco P, Lepore M, Ciofetta M, Fanelli C, Brunetti P, Bolli GB: Effect of recent, antecedent hypoglycemia and response of cortisol per se', on responses to subsequent hypoglycaemia in humans (Abstract). Diabetologia 40 (Suppl. 1):A27, 1997
72. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB: Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251:E442-E447, 1986
73. Uehara Y, Nipper V, McCall AL: Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol 272:E716-E719, 1997
74. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ: Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333:1726-1731, 1995
75. Chipkin SR, Van Bueren A, Bercel E, Garrison CR, McCall AL: Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature. Neurochem Res 23:649-656, 1998
76. Long RG, Albuquerque RH, Prata A, Barnes AJ, Adrian TE, Christofides ND, Bloom SR: Responses of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypogly-cemia in Chagas's disease. Gut 21:772-777, 1980
77. Sasaki K, Matsuhashi A, Murabayashi S, Aoyagi K, Baba T, Matsunaga M, Takebe K: Hormonal response to insulin-induced hypoglycemia in patients with Shy-Drager syndrome. Metabolism 32:977-981, 1983
78. Towler DA, Havlin CE, Craft S, Cryer P: Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798, 1993
79. Hilsted J, Frandsen H, Holst JJ, Christensen NJ, Nielsen SL: Plasma glucagon and glucose recovery after hypoglycemia: the effect of total autonomic blockade. Acta Endocrinol 125:466-469, 1991
80. Bishop AE, Polak JM, Green IC, Bryant MG, Bloom SR: The location of VIP in the pancreas of man and rat. Diabetologia 18:73-78, 1980
81. Fahrenkrug J, Pedersen JH, Yamashita Y, Ottesen B, Hokfelt T, Lundberg JM: Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man, Regul Pept 18:51-61, 1987
82. Rothschild AH, Weinberg CR, Halter JB, Porte D Jr, Pfeifer MA: Sensitivity of R-R variation and Valsalva ratio in assessment of diabetic autonomic neuropathy. Diabetes Care 42:1549-1554, 1987
83. Havel P, Ahren B: Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 46:801-807, 1997
84. Gerich J, Langlois M, Noacco C, Karam J, Forsham P: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182:171-173, 1973
85. Singer-Granick C, Huffman RP, Kerensky K, Drash AL, Becker DJ: Glucagon responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care 11:643-649, 1988
86. Hoffman RP, Arslanian S, Drash AL, Becker DJ: Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM. J Pediatr Endocrinol 7:235-244, 1994
87. Matyka K, Crawford C, Wiggs L, Stores G, Dunger DB: High prevalence of nocturnal hypoglycemia in children with type-1 diabetes: analysis of sleep physiology (Abstract). Diabetologia 40:A237, 1997
88. Shi ZQ, Rastogi KS, Lekas M, Efendic S, Drucker DJ, Vranic M: Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats. Endocrinology 137:3193-3199, 1996
89. The Diabetes Control and Complications Trial Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual (β-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-36, 1986
90. Madsbad S: Prevalence of residual B cell function and its metabolic consequences In type 1 (insulin-dependent) diabetes. Diabetologia 24:141-147, 1983
91. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroen-docrine responses to, symptoms of, and cognitive function during hypogly-cemia in intensively treated patients with short-term IDDM. Diabetes 42:1083-1689, 1993
92. Liu DT, Adamson UC, Lins P-ES, Kollind ME, Moberg EA, Andréasson K: Inhibitory effect of circulating insulin on glucagon secretion during hypo-glycemia in type 1 diabetic patients. Diabetes Care 15:59-65, 1992
93. Fukuda M, Tanaka A, Tuhara Y, Ikegami H, Yamamoto Y, Kumahara Y, Shima K: Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control. Diabetes 37:81-88, 1988
94. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-274, 1986
95. Steffes M, Tamborlane W, Becker D, Palmer J, Cleary P: The effect of intensive diabetes treatment on residual β-cell function in the diabetes control and complications trial (DCCT) (Abstract). Diabetes 45 (Suppl. 2): 18A, 1996
96. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622-626, 1996
97. Hoeldtke RD, Boden G: Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med 120:512-517, 1994
98. Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte D Jr: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31:339-345, 1982
99. Schnell O, Kirsch CM, Stemplinger J, HaslbeckM, Standl E: Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38:1345-1352, 1995
100. Hofflnan RP, Sinkey CA, Kienzle MG, Anderson EA: Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy. Diabetes 42:375-380, 1993
101. Ewing DJ, Neilson JM, Travis P: New method for assessing cardiac parasym-pathetic activity using 24 h electrocardiograms. Br Heart J 52:396-402, 1984
102. Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Sindaco PD, Scionti L, Brunetti P, Bolli GB: Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a non-selective defect. Diabetes 46:814-823, 1997
103. Myrsen U, Keymeulen B, Pipeleers DG, Sundler F: Beta cells are important for islet innervation: evidence from purified rat islet-cell grafts. Diabetolo-gia 39:54-59, 1906
104. Havel PJ, Duesberg C, Elliott DE, Gingerich RL, Feldman EC, Nelson RW: Impaired glucagon responses to insulin-induced hypoglycemia (IIH) are associated with impaired activation of pancreatic parasympathetic nerves in dogs with spontaneous diabetes mellitus (Abstract). Diabetes 44 (Suppl. 1):216A, 1995
105. Dagogo-Jack S, Rattarasam C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
106. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vencenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusnio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypogly-caemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
107. Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadlnovic C, Bernstein L, Schneider M, Liang KY, Gabbay KH, Rubenstein AH, Porte D Jr: Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med 308:119-125, 1983
108. Battezzuti A, Luzi L, Perseghin G, Bianchi E, Spotti D, Secchi A, Vergani S, Di Carlo V, Pozza G: Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation. Eur J Clin Invest 24:751-758, 1994
109. Diem P, Redmon JB, Abid M, Moran A, Sutherland DER, Halter JB, Robertson RP: Glucagon, catecholamine and pancreatic polypeptide secretion in type 1 diabetic recipients of pancreas allografts. J Clin Invest 86:2008-2013, 1990
110. Barrou Z, Seaquist ER, Robertson RP: Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia, Diabetes 43:661-666, 1994
111. Ostman J, Bounder J, Gunnarsson R, Brattstrom C, Tyden G, Wahren J, Groth CG: Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes 38:88-93, 1989
112. Jaspan JB, Ruddick J, Rayfield E: Transhopatic glucagon gradients in man: evidence for glucagon extraction by human liver. J Clin Endocrinol Metab 58:287-292, 1984
113. Herold KC, Jaspan JB: Hepatic glucagon clearance during insulin induced hypoglycemia. Horm Metab Res 18:431-435, 1986
114. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A: Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 40:1110-1112, 1997